BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33472858)

  • 1. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
    Brownlie D; Doughty-Shenton D; Yh Soong D; Nixon C; O Carragher N; M Carlin L; Kitamura T
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The breast tumor microenvironment alters the phenotype and function of natural killer cells.
    Krneta T; Gillgrass A; Chew M; Ashkar AA
    Cell Mol Immunol; 2016 Sep; 13(5):628-39. PubMed ID: 26277898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer.
    Kitamura T; Doughty-Shenton D; Cassetta L; Fragkogianni S; Brownlie D; Kato Y; Carragher N; Pollard JW
    Front Immunol; 2017; 8():2004. PubMed ID: 29387063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk.
    Elhaik-Goldman S; Kafka D; Yossef R; Hadad U; Elkabets M; Vallon-Eberhard A; Hulihel L; Jung S; Ghadially H; Braiman A; Apte RN; Mandelboim O; Dagan R; Mizrachi-Nebenzahl Y; Porgador A
    PLoS One; 2011; 6(8):e23472. PubMed ID: 21887255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.
    Bernard PL; Delconte R; Pastor S; Laletin V; Costa Da Silva C; Goubard A; Josselin E; Castellano R; Krug A; Vernerey J; Devillier R; Olive D; Verhoeyen E; Vivier E; Huntington ND; Nunes J; Guittard G
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35589278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
    J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
    Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
    Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
    Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
    J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF.
    Kitamura T; Kato Y; Brownlie D; Soong DYH; Sugano G; Kippen N; Li J; Doughty-Shenton D; Carragher N; Pollard JW
    Cancer Immunol Res; 2019 Dec; 7(12):2052-2064. PubMed ID: 31615815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
    Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Höglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Kärre K; Shibuya A; Carbone E; Colucci F
    J Clin Invest; 2009 May; 119(5):1251-63. PubMed ID: 19349689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.
    Diab M; Glasner A; Isaacson B; Bar-On Y; Drori Y; Yamin R; Duev-Cohen A; Danziger O; Zamostiano R; Mandelboim M; Jonjic S; Bacharach E; Mandelboim O
    Eur J Immunol; 2017 Apr; 47(4):692-703. PubMed ID: 28191644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
    Gillgrass AE; Chew MV; Krneta T; Ashkar AA
    BMC Cancer; 2015 Apr; 15():293. PubMed ID: 25879689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
    Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
    J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
    Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.